Cytokinetics heart failure drug turned back by FDA
The company is turning its attention to another drug, which is in a late-stage clinical trial in a genetic heart disease, obstructive hypertrophic cardiomyopathy, that in 1993 killed Boston Celtics star Reggie Lewis.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Cardiology | Cardiomyopathy | Clinical Trials | Genetics | Health Management | Heart | Heart Disease | Heart Failure | Hypertrophic Cardiomyopathy | Pharmaceuticals